Clinical Trial Update: Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings

View source ↗

Summary

A completed clinical trial evaluating the impact of afatinib on quality of life and symptom burden in Greek patients with advanced non-small cell lung cancer in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Non-Small-Cell Lung | Status: COMPLETED | Results posted: 2022-04-27